For more information: Sheldon Baker
Baker Dillon Group
559.325.7191
Info@BakerDillon.com
Daiwa Health Development Introduces Double Strength BRM4™ Rice Bran Arabinoxylan
Compound
(Los Angeles, CA) November 17, 2008 – Daiwa Health Development has introduced
double strength BRM4™, a 500mg, 60 count version of its patented immune enhancing
complex to the health professional marketplace. BRM4™, with its active ingredient
Rice Bran Arabinoxylan Compound (RBAC), has been clinically shown to triple
Natural Killer (NK) cell activity, increase T and B lymphocytes and demonstrate
vital antioxidant and anti-inflammatory action.
RBAC, a polysaccharide dietary fiber derived from rice bran, is modified by
a Shiitake mushroom enzyme using a patented biotechnology process. As an immune
modulator, BRM4™ retains its effectiveness over time. Clinical trials have
shown BRM4 is safe with no side effects. In over 12 years of worldwide use,
there have been no reported cases of drug interactions. BRM4™ is recognized
as the gold standard immune product worldwide for people with seriously compromised
immune systems.
BRM4™ in a 250mg dosage, 60 count bottle, has been available through physicians
for over 10 years. In pre-clinical studies, the power of BRM4™ multiplies T
cell levels up to 200%. The enhanced activity of helper T cells promotes the
proliferation of cytotoxic T and B cells for essential immune support. Helper
T cells also signal plasma B cells when they encounter their cognate antigen
to secure a health production of antibodies. Furthermore, BRM4™ supports the
body’s natural production of cytokines to control inflammatory response.
Double Strength BRM4™ is now available to health professionals in the U.S.
For more product and ordering information call 877.434.3633 or email Info@DHDMED.com.
Los Angeles-based Daiwa Health Development, Inc. is a subsidiary of Daiwa Pharmaceutical
Co. Ltd. based in Tokyo, Japan. Daiwa has become a leading research and manufacturing
company, striving to create new value in the field of bioscience. Daiwa focuses
on the manufacturing and distribution of nutraceuticals, functional foods and
cosmetics.